🇺🇸 FDA
Pipeline program

Spironolactone 25mg

Monitor-AF

Phase 2 small_molecule active

Quick answer

Spironolactone 25mg for Atrial Fibrillation is a Phase 2 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Atrial Fibrillation
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials